A detailed release of information in regards to the recent rejection of Flibanserin by the Food and Drug Administration. In this text, you will learn why Flibanserin was rejected, what the proposed effects of Flibanserin are, about the results of the clinical trial, and what the future holds for Flibanserin and women suffering from a decreased sex drive or Hypoactive Sexual Desire Disorder.

Sensuality and sexuality play a vital role in women’s health and when women are educated to believe they must conform to certain sexual beliefs, those beliefs are hard to change. Those beliefs are discussed in the Journal of the American Medical Association, which reported that forty three percent of American women have some form of female sexual dysfunction (FSD).

Flibanserin, a drug that can solve the problems associated with a female loss of libido and Hypoactive Sexual Desire Disorder, is expected to be named Girosa after the clinical trial process. While this has not yet been confirmed, let’s take a look at what Girosa is and how it works.

Studies show that 10 to 20% of women experience a loss of libido and lack of sexual interest, often caused by HSDD – Hypoactive Sexual Desire Disorder. However, recent tests show that Flibanserin has the potential to increase female libido and sex drive, and solve the problem of HSDD. Learn more about how in this article.

Flibanserin is undergoing a Phase III Treatment Clinical Trial with the FDA. In this article, learn more about what a clinical trial is and how it will affect Flibanserin, the necessity of a clinical trial and what it aims to prove, and more!

Flibanserin is currently undergoing a Phase III Clinical Trial with the Food and Drug Administration of the United States. This is the final trial that needs to take place before we see if Flibanserin will be prescribed to consumers. It is expected that the trial will end in February of 2011. So far, the results are pleasing.

Female Libido – the sex drive: A number of psychological and physical causes exist behind a diminished interest in sexual activity and intercourse. But what exactly are the causes? Is there anything you can do about them? Let’s take a look at the top causes behind a lower female libido.

Flibanserin is a drug introduced by Boehringer Ingelheim that claims to improve the sexual experience of women – working much like how Viagra works for men. Currently, this drug is undergoing clinical trials to see if it will be released on the market. This article provides a complete overview of what Flibanserin is and how it works.

Does Flibanserin appear to have a significant effect on increasing the sexual desire of women who suffer from Hypoactive Sexual Desire Disorder? This is an analysis of the data from clinical trials and a look at how Flibanserin works, how it affects the brain, and whether or not it will be a useful tool for women. This article covers the foundation of Flibanserin’s effect on sexual desire in an easy to understand way.

A brief overview of, and introduction to, the pharmaceutical drug known as Flibanserin. Included is an analysis of the reported effects of Flibanserin and data from the most recent clinical trials. If you’re searching for a way to increase female sexual satisfaction, this drug may soon impact your life in a positive way. Learn more by reading this informative article.